This entry was posted on 11/28/2007 3:27 PM and is filed under ARTICLES.
The news of an impending root canal, cavity filling or crown replacement could be enough to put a damper on anyone’s day—unless you’re Lifecore Biomedical, Inc. (Nasdaq: LCBM) or BioMimetic Therapeutics, Inc. (Nasdaq: BMTI), two companies that are benefiting from increased spending on dental care.
The American Dental Association predicts that dental care spending will grow to $146.9 billion by 2014 from $84.1 billion in 2005. Demand is rising due to population growth, the aging of baby boomers and increased awareness of the benefits of preventive dentistry in combating disease.
The market for advanced dental technologies includes some 160,000 practicing dentists in the United States and at least 700,000 dentists worldwide. U.S. dentists perform over 200 million hard tissue dental procedures annually, including cavity preparation, inlays, crowns and root canals. In addition, some 1.2 million soft tissue procedures typically involving gum-line alteration or gum grafts are performed annually. . .
